Research Papers:

Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma

Xiangjun Kong, Wenyong Wu, Yan Yuan, Vijay Pandey, Zhengsheng Wu, Xuefei Lu, Weijie Zhang, Yijun Chen, Mingming Wu, Min Zhang, Gaopeng Li, Sheng Tan, Pengxu Qian, Jo K. Perry, Peter E. Lobie and Tao Zhu _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:29465-29479. https://doi.org/10.18632/oncotarget.8781

Metrics: PDF 907 views  |   HTML 1478 views  |   ?  


Xiangjun Kong1,2,*, Wenyong Wu3,*, Yan Yuan1,2, Vijay Pandey4, Zhengsheng Wu5, Xuefei Lu1,2, Weijie Zhang1,2, Yijun Chen4, Mingming Wu1,2, Min Zhang1,2, Gaopeng Li1,2, Sheng Tan1,2, Pengxu Qian1,2, Jo K. Perry6, Peter E. Lobie4,7, Tao Zhu1,2

1The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui, China

2Hefei National Laboratory for Physical Sciences at Microscale, Hefei, Anhui, China

3Department of General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

4Cancer Science Institute of Singapore and Department of Pharmacology, National University of Singapore, Singapore

5Department of Pathology, Anhui Medical University, Hefei, Anhui, China

6Liggins Institute, University of Auckland, Auckland, New Zealand

7National University Cancer Institute of Singapore, National University Health System, Singapore

*These authors have contributed equally to this work

Correspondence to:

Tao Zhu, e-mail: zhut@ustc.edu.cn

Peter E. Lobie, e-mail: csipel@nus.edu.sg

Keywords: growth hormone, prolactin, hepatocellular carcinoma, oncogenicity, survival

Received: May 19, 2015    Accepted: March 24, 2016    Published: April 18, 2016


The death rates of hepatocellular carcinoma (HCC) are extremely high due to the paucity of therapeutic options. Animal models and anecdotal clinical evidence indicate a potential role of hGH and hPRL in HCC. However, the prognostic relevance and the functional role of tumor expression of these hormones in human HCC are not defined. Herein, we analyzed the mRNA and protein expression of hGH and hPRL in histopathological samples of non-neoplastic liver and HCC by in situ hybridization, PCR and immunohistochemistry techniques. Increased mRNA and protein expression of both hormones was observed in HCC compared with non-neoplastic liver tissues. hGH expression was significantly associated with tumor size and tumor grade. No significant association was observed between the expression of hPRL and any histopathological features. Amplification of both hGH and hPRL genes in HCC was observed when compared to non-neoplastic tissue. Expression of both hGH and hPRL was associated with worse relapse-free and overall survival in HCC patients. In vitro and in vivo functional assays performed with HCC cell lines demonstrated that autocrine expression of hGH or hPRL in HCC cells increased STAT3 activation, oncogenicity and tumor growth while functional antagonism with hGH-G120R significantly reduced these parameters. Hence, tumor expression of hGH/hPRL is associated with a worse survival outcome for patients with HCC and hGH/hPRL function as autocrine/paracrine promoters of HCC progression.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 8781